Current Views“Dirty little secrets”—Endotoxin contamination of recombinant proteins
Introduction
Lipopolysaccharide (LPS), an integral component of the outer membrane of Gram negative bacteria, is a potent stimulant of the immune system [1]. LPS is the main cause of septic shock in humans, a syndrome characterised by the massive release of proinflammatory cytokines, activation of clotting and complement cascades, and activation of leukocytes. Following the discovery of Toll in Drosophila, the identification of a family of mammalian Toll-like receptors (TLRs) that recognise and signal in response to conserved molecular patterns (pathogen-associated molecular patterns) present within bacteria has transformed our understanding of innate immunity [2], [3], [4], [5], [6].
Section snippets
TLR4 and its agonists
Many TLR agonists are bacterial in origin reflecting the variety of microbial components that need to be recognised by the innate immune system (Fig. 1). Upon activation, TLRs signal as dimers, complexing via their intracellular Toll/interleukin-1 receptor (TIR) domains with a family of adaptor proteins in TLR-specific patterns. This results in the activation of downstream pathways including the NF-κB pathway, the MAP kinases, phosphatidylinositol-3′-kinase (PI-3K), and the interferon
The nature of the stimulus
Recently, a body of evidence has emerged to suggest that some of the effects previously attributed to the TLR4 agonists HSP60 and HSP70 may be the direct result of low amounts of endotoxin contained within the bacterial-derived recombinant proteins used experimentally to investigate their roles in vitro [34], [35], [36], though studies controlling carefully for endotoxin have still identified roles for these proteins in the activation of TLR4 [37]. There is also recent evidence that the heat
Detecting the contaminants
Given the potency of the many bacterial products that may contribute to signalling through one or more of the TLRs, it is vital that effects attributable to such products are differentiated from effects relating to the protein of interest. This relies on our ability not only to detect and quantify accurately the activity of the bacterial contaminants present but also to remove or neutralise them. It is important to emphasize that the methods available target LPS alone, thus failing to account
Decontaminating the contaminants
The removal of endotoxin from proteins is difficult [64]. If LPS is the only bacterial contaminant present, a number of methods have been described in the literature for its removal [65], [66], [67]. These include adsorption by activated carbon, anion-exchange chromatography, Triton X phase separation, the use of polymeric matrices and treatment with polymyxin B (PMB) or histamine-immobilised sepharose. Most have been designed with a clinical purpose in mind, producing products that do not
Future
The discovery of the TLRs is revolutionising our understanding of innate immunity and it is now clear that the TLRs represent a very specific mechanism for the recognition of bacterial molecular patterns. TLR signalling is complex but although much headway has been made, we still are far from understanding all the interactions that take place during signal transduction. TLR4 has been the centre of intense interest and a number of exogenous and endogenous agonists have been proposed. The full
References (87)
- et al.
Structure and function of lipopolysaccharides
Microbes Infect
(2002) How Toll-like receptors signal: what we know and what we don’t know
Curr Opin Immunol
(2006)- et al.
MD-2 binds to bacterial lipopolysaccharide
J Biol Chem
(2001) - et al.
Lipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster
Trends Immunol
(2002) - et al.
The extra domain A of fibronectin activates Toll-like receptor 4
J Biol Chem
(2001) - et al.
Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids
J Biol Chem
(2003) - et al.
Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells
J Biol Chem
(2001) - et al.
HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway
J Biol Chem
(2002) An innate sense of danger
Semin Immunol
(1998)- et al.
Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages
J Biol Chem
(2003)